Journals / Turkish Journal of Endocrinology and Metabolism / 2021 / Cilt: 25 - Sayı: 2

Foot Ulcer a Devastating Complication ofDiabetes Mellitus:A Single-Center Experience of 400 Patients

Diyabetes Mellitusun Yıkıcı Bir Komplikasyonu Olan Ayak Ülseri: 400 Hastadan Oluşan Tek Merkez Deneyimi

Pages
133–141
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Peripheral ar-terial disease [odds ratio (OR): 2.183, 95% confidence interval (CI): 1.242-3.837, p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To identify the clinical predictors of amputation outcomes inpatients with diabetic foot ulcers (DFUs) and the management of such pa-tients.
📊
Key Findings & Data:Material and Methods: Four hundred (273 men; 127 women) pa- tients with DFUs, who were followed at our clinic between 2008-2014, were included.
💡
Conclusion & Impact:Peripheral ar-terial disease [odds ratio (OR): 2.183, 95% confidence interval (CI): 1.242-3.837, p
🔬Design:Research Article
📍Scope:2008-2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To identify the clinical predictors of amputation outcomes inpatients with diabetic foot ulcers (DFUs) and the management of such pa-tients. Material and Methods: Four hundred (273 men; 127 women) pa- tients with DFUs, who were followed at our clinic between 2008-2014, were included. Patients' demographic characteristics, glycemic parameters, and diabetic complications were evaluated. The amputations were classified as minor (distal to metatarsus) and major (Chopart, and below or upper knee) amputations. Results: The mean age of the patients was 62.4±10.5 years.Three hundred and ninety-five patients had type 2 diabetes mellitus. The mean diabetes duration was 17±8 years. The rate of chronic diabetic com-plications consisting of neuropathy, nephropathy, and retinopathy were 97.5%, 81.3%, and 94.8%, respectively. Osteomyelitis and peripheral ar-terial disease rates were 327 (81.8%) and 265 (66%), respectively. The majority of the foot ulcers were of Wagner grade 3 (53.2%) and 4 (27.5%). According to the initial clinical considerations, 60% of the patients were administered empirical antibiotic therapy for infection. The minor and major amputation rates were 110 (25.5%) and 146 (36.3%), respectively. The average glycosylated hemoglobin value was 8.9±2.3%. Peripheral ar-terial disease [odds ratio (OR): 2.183, 95% confidence interval (CI): 1.242-3.837, p

Özet

Amaç: Diyabetik ayak ülseri ile amputasyon sonuçlarının, klinik belirleyi- cilerini ve hastaların yönetimini sunmaktır. Gereç ve Yöntemler: Çalış- maya, 2008 ve 2014 yılları arasında kliniğimizde izlenen diyabetik ayakülserli 400 (273 erkek, 127 kadın) hasta dâhil edildi. Hastaların demogra- fik özellikleri, glisemik parametreleri ve diyabetik komplikasyonları değer- lendirildi. Amputasyonlar, minör (metatarsın distalinde) ve majör (Chopartve diz altı veya diz üstü) amputasyonlar olarak sınıflandırıldı. Bulgular:Hastaların yaş ortalaması 62,4±10,5 yıl idi ve 395’i tip 2 diyabetes melli- tuslu idi. Ortalama diyabet süresi 17±8 yıl idi. Kronik diyabetik komplikas- yonlar olan nöropati, nefropati ve retinopati için oranlar sırasıyla %97,5;%81,3 ve %94,8 idi. Osteomiyelit ve periferik arteriyal hastalık oranları, sı- rasıyla 327 (%81,8) ve 265 (%66) saptandı. Ayak ülserlerinin çoğu, Wag- ner 3 (%53,2) ve 4 (%27,5) düzeyinde bulundu. İlk klinik değerlendirmeyegöre hastaların %60’ına enfeksiyon nedeniyle ampirik antibiyotik tedavisiverildi. Minör ve majör amputasyon oranları sırasıyla 110 (%25,5) ve 146(%36,3) idi. Hastaların ortalama glikozile hemoglobin düzeyi %8,9±2,3idi. Periferik arteriyal hastalık (olasılık oranı: 2,183; %95 güven aralığı:1,242-3,837; p

🔖

Cite This Article

KESİKTAŞ, E., TETİKER, T., EVRAN, M., AKKUŞ, G., SERT, M., BİÇER, Ö. S., KURTARA, B., AKSUNGU, E. (2022). Foot Ulcer a Devastating Complication ofDiabetes Mellitus:A Single-Center Experience of 400 Patients. Turkish Journal of Endocrinology and Metabolism, Cilt: 25 - Sayı: 2, 133–141. https://ajindex.com/articles/605329

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Dalla Paola L, Faglia E. Treatment of diabetic foot ulcer: an overview strategies for clinical approach. Curr Diabetes Rev. 2006
  2. [Crossref] [PubMed] 2. International Diabetes Federation. IDF Diabetes Atlas Eighth edition 2017. Available from: [Link] 3. Reiber GE, Lipsky BA, Gibbons GW. The burden of diabetic foot ulcers. Am J Surg. 1998
  3. 5S-10S. [Crossref] [PubMed] 4. Gordois A, Scuffham P, Shearer A, Oglesby A, To- bian JA. The health care costs of diabetic periphe- ral neuropathy in the US. Diabetes Care. 2003
  4. [Crossref] [PubMed] 5. NICE. Diabetic foot problems: prevention and ma- nagement. NICE guideline [NG19]. 2015. Available from: date: 26 August 2015 [Link] 6. Calderini C, Cioni F, Haddoub S, Maccanelli F, Ma- gotti MG, Tardio S. Therapeutic approach to "diabe- tic foot" complications. Acta Biomed. 2014
  5. [PubMed] 7. Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981
  6. [Crossref] [PubMed] 8. Game FL, Apelqvist J, Attinger C, Hartemann A, Hinchliffe RJ, Löndahl M, Price PE, Jeffcoate WJ
  7. In- ternational Working Group on the Diabetic Foot. Ef- fectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes Metab Res Rev. 2016
  8. 32 Suppl 1:154-168. [Crossref] [PubMed] 9. Zelmanovitz T, Gerchman F, Balthazar AP, Thoma- zelli FC, Matos JD, Canani LH. Diabetic nephropathy. Diabetol Metab Syndr. 2009
  9. [Crossref] [Pub- Med] [PMC] 10. Assaad-Khalil SH, Zaki A, Abdel Rehim A, Megallaa MH, Gaber N, Gamal H, Rohoma KH. Prevalence of diabetic foot disorders and related risk factors among Egyptian subjects with diabetes. Prim Care Diabetes. 2015
  10. [Crossref] [PubMed] 11. Guest JF, Fuller GW, Vowden P. Diabetic foot ulcer management in clinical practice in the UK: costs and outcomes. Int Wound J. 2018
  11. [Crossref] [PubMed] 12. Treece KA, Macfarlane RM, Pound N, Game FL, Jeff- coate WJ. Validation of a system of foot ulcer clas- sification in diabetes mellitus. Diabet Med. 2004
  12. [Crossref] [PubMed] 13. Lipsky BA
  13. International consensus group on diag- nosing and treating the infected diabetic foot. A re- port from the international consensus on diagnosing and treating the infected diabetic foot. Diabetes Metab Res Rev. 2004
  14. 20 Suppl 1:S68-77. [Crossref] [PubMed] 14. Ikem R, Ikem I, Adebayo O, Soyoye D. An assess- ment of peripheral vascular disease in patients with diabetic foot ulcer. Foot